Catalano Michael A, Toubat Omar, Gillinov Lauren, Lawrence Kendall M, Zhao Yu, Kelly John J, Goel Nicholas J, Sperry Alexandra, Szeto Wilson Y, Brown Chase R, Desai Nimesh D
Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, Pa.
Leonard Davis Institute, University of Pennsylvania, Philadelphia, Pa.
JTCVS Open. 2025 Jun 9;26:22-33. doi: 10.1016/j.xjon.2025.05.009. eCollection 2025 Aug.
Valve selection in acute type A aortic dissection (ATAAD) requiring aortic root replacement is challenging given the clinical acuity, unknown patient preferences, risk of surgical bleeding, and limited life expectancy. We sought to identify long-term outcomes of mechanical versus bioprosthetic aortic root replacement in young patients with ATAAD.
Retrospective review of our institution's database of ATAAD was conducted to identify patients aged 65 years and younger who underwent mechanical Bentall (mech-Bentall) or bioprosthetic Bentall (bio-Bentall) for ATAAD from 2002 to 2022. The primary end point was 10-year survival, which was compared in a propensity score-matched cohort and multivariable Cox proportional hazards model. A composite outcome of 10-year freedom from death, stroke, major bleeding, and valvular reintervention was assessed as a secondary end point.
Of 1114 patients who underwent ATAAD repair, there were 79 mech-Bentalls and 67 bio-Bentalls in patients aged 65 years or younger. Patients undergoing mech-Bentall were younger, and they were less likely to undergo an extended arch operation; there was no difference in gender, race, comorbidities, or malperfusion on presentation. In a propensity score-matched analysis, mech-Bentall patients demonstrated a nonsignificant increase in 10-year mortality ( = .058) and demonstrated higher rates of the composite end point ( = .026). In a Cox proportional hazards model, mech-Bentall (hazard ratio, 1.892; = .023) was independently associated with 10-year composite end point occurrence.
There is no survival advantage of mech-Bentall in ATAAD in young patients at 10 years, and it is associated with a significantly higher rate of morbid complications. When the aortic valve cannot be spared, bio-Bentall should be considered in ATAAD, even in young patients.
鉴于急性A型主动脉夹层(ATAAD)患者的临床急症情况、患者偏好未知、手术出血风险以及预期寿命有限,对于需要进行主动脉根部置换的患者而言,瓣膜选择颇具挑战性。我们试图确定年轻ATAAD患者行机械瓣与生物瓣主动脉根部置换的长期预后。
对本机构的ATAAD数据库进行回顾性分析,以确定2002年至2022年间年龄在65岁及以下、因ATAAD接受机械Bentall手术(mech-Bentall)或生物瓣Bentall手术(bio-Bentall)的患者。主要终点为10年生存率,在倾向评分匹配队列和多变量Cox比例风险模型中进行比较。将10年无死亡、中风、大出血和瓣膜再次干预的复合结局作为次要终点进行评估。
在1114例行ATAAD修复的患者中,65岁及以下患者有79例行mech-Bentall手术,67例行bio-Bentall手术。接受mech-Bentall手术的患者更年轻,且进行主动脉弓延伸手术的可能性更小;在性别、种族、合并症或就诊时的灌注不良方面无差异。在倾向评分匹配分析中,mech-Bentall手术患者的10年死亡率有非显著性增加(P = 0.058),且复合终点发生率更高(P = 0.026)。在Cox比例风险模型中,mech-Bentall手术(风险比,1.892;P = 0.023)与10年复合终点的发生独立相关。
对于年轻的ATAAD患者,mech-Bentall手术在10年时并无生存优势,且与更高的严重并发症发生率相关。当无法保留主动脉瓣时,即使是年轻患者,ATAAD患者也应考虑行bio-Bentall手术。